186 related articles for article (PubMed ID: 23847096)
1. N6-isopentenyladenosine, an endogenous isoprenoid end product, directly affects cytotoxic and regulatory functions of human NK cells through FDPS modulation.
Ciaglia E; Pisanti S; Picardi P; Laezza C; Malfitano AM; D'Alessandro A; Gazzerro P; Vitale M; Carbone E; Bifulco M
J Leukoc Biol; 2013 Dec; 94(6):1207-19. PubMed ID: 23847096
[TBL] [Abstract][Full Text] [Related]
2. N6-isopentenyladenosine affects cytotoxic activity and cytokines production by IL-2 activated NK cells and exerts topical anti-inflammatory activity in mice.
Ciaglia E; Pisanti S; Picardi P; Laezza C; Sosa S; Tubaro A; Vitale M; Gazzerro P; Malfitano AM; Bifulco M
Pharmacol Res; 2014 Nov; 89():1-10. PubMed ID: 25063359
[TBL] [Abstract][Full Text] [Related]
3. Effect of influenza A infection on umbilical cord blood natural killer function regulation with interleukin-15.
Lin SJ; Cheng PJ; Lin TY; Lee PT; Hsiao HS; Kuo ML
J Infect Dis; 2012 Mar; 205(5):745-56. PubMed ID: 22262794
[TBL] [Abstract][Full Text] [Related]
4. Human NK cells require caspases for activation-induced proliferation and cytokine release but not for cytotoxicity.
Ussat S; Scherer G; Fazio J; Beetz S; Kabelitz D; Adam-Klages S
Scand J Immunol; 2010 Nov; 72(5):388-95. PubMed ID: 21039733
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of norepinephrine-mediated inhibition of human NK cytotoxic functions: inhibition of cytokine secretion, target binding, and programming for cytotoxicity.
Gan X; Zhang L; Solomon GF; Bonavida B
Brain Behav Immun; 2002 Jun; 16(3):227-46. PubMed ID: 12009684
[TBL] [Abstract][Full Text] [Related]
6. Phenotype and function of natural killer cells in systemic lupus erythematosus: excess interferon-γ production in patients with active disease.
Hervier B; Beziat V; Haroche J; Mathian A; Lebon P; Ghillani-Dalbin P; Musset L; Debré P; Amoura Z; Vieillard V
Arthritis Rheum; 2011 Jun; 63(6):1698-706. PubMed ID: 21370226
[TBL] [Abstract][Full Text] [Related]
7. Measurement of NK activity in whole blood by the CD69 up-regulation after co-incubation with K562, comparison with NK cytotoxicity assays and CD107a degranulation assay.
Dons'koi BV; Chernyshov VP; Osypchuk DV
J Immunol Methods; 2011 Sep; 372(1-2):187-95. PubMed ID: 21839083
[TBL] [Abstract][Full Text] [Related]
8. Cellular interactions of synovial fluid γδ T cells in juvenile idiopathic arthritis.
Bendersky A; Marcu-Malina V; Berkun Y; Gerstein M; Nagar M; Goldstein I; Padeh S; Bank I
J Immunol; 2012 May; 188(9):4349-59. PubMed ID: 22450805
[TBL] [Abstract][Full Text] [Related]
9. NK cells from malignant pleural effusions are not anergic but produce cytokines and display strong antitumor activity on short-term IL-2 activation.
Vacca P; Martini S; Garelli V; Passalacqua G; Moretta L; Mingari MC
Eur J Immunol; 2013 Feb; 43(2):550-61. PubMed ID: 23192659
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-15 activated bovine natural killer cells express CD69 and produce interferon-γ.
Lund H; Boysen P; Dean GA; Davis WC; Park KT; Storset AK
Vet Immunol Immunopathol; 2012 Nov; 150(1-2):79-89. PubMed ID: 23021353
[TBL] [Abstract][Full Text] [Related]
11. Production of tumor necrosis factor-alpha and interferon-gamma from human peripheral blood lymphocytes by MGN-3, a modified arabinoxylan from rice bran, and its synergy with interleukin-2 in vitro.
Ghoneum M; Jewett A
Cancer Detect Prev; 2000; 24(4):314-24. PubMed ID: 11059563
[TBL] [Abstract][Full Text] [Related]
12. Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune response.
Fehniger TA; Shah MH; Turner MJ; VanDeusen JB; Whitman SP; Cooper MA; Suzuki K; Wechser M; Goodsaid F; Caligiuri MA
J Immunol; 1999 Apr; 162(8):4511-20. PubMed ID: 10201989
[TBL] [Abstract][Full Text] [Related]
13. The role of IL-4 in proliferation and differentiation of human natural killer cells. Study of an IL-4-dependent versus an IL-2-dependent natural killer cell clone.
Hayakawa K; Salmeron MA; Kornbluth J; Bucana C; Itoh K
J Immunol; 1991 Apr; 146(7):2453-60. PubMed ID: 1900882
[TBL] [Abstract][Full Text] [Related]
14. Expression and function of CD7 molecule on human natural killer cells.
Rabinowich H; Pricop L; Herberman RB; Whiteside TL
J Immunol; 1994 Jan; 152(2):517-26. PubMed ID: 7506726
[TBL] [Abstract][Full Text] [Related]
15. Natural killer (NK) cell stimulatory factor or IL-12 has differential effects on the proliferation of TCR-alpha beta+, TCR-gamma delta+ T lymphocytes, and NK cells.
Perussia B; Chan SH; D'Andrea A; Tsuji K; Santoli D; Pospisil M; Young D; Wolf SF; Trinchieri G
J Immunol; 1992 Dec; 149(11):3495-502. PubMed ID: 1358972
[TBL] [Abstract][Full Text] [Related]
16. HCMV infection of PDCs deviates the NK cell response into cytokine-producing cells unable to perform cytotoxicity.
Cederarv M; Söderberg-Nauclér C; Odeberg J
Immunobiology; 2009; 214(5):331-41. PubMed ID: 19152985
[TBL] [Abstract][Full Text] [Related]
17. In-vitro activation of natural killer cells from regional lymph nodes of melanoma patients with interleukin-2 and interleukin-15.
Vuletić AM; Jovanić IP; Jurišić VB; Milovanović ZM; Nikolić SS; Tanić NT; Konjević GM
Melanoma Res; 2015 Feb; 25(1):22-34. PubMed ID: 25380182
[TBL] [Abstract][Full Text] [Related]
18. NK cell activity in tuberculosis is associated with impaired CD11a and ICAM-1 expression: a regulatory role of monocytes in NK activation.
Schierloh P; Alemán M; Yokobori N; Alves L; Roldán N; Abbate E; del C Sasiain M; de la Barrera S
Immunology; 2005 Dec; 116(4):541-52. PubMed ID: 16313368
[TBL] [Abstract][Full Text] [Related]
19. The potential markers of NK-92 associated to cytotoxicity against K562 cells.
Song X; Xu C; Wu X; Zhao X; Fan J; Meng S
Biologicals; 2020 Nov; 68():46-53. PubMed ID: 32933840
[TBL] [Abstract][Full Text] [Related]
20. Expansion of functionally skewed CD56-negative NK cells in chronic hepatitis C virus infection: correlation with outcome of pegylated IFN-alpha and ribavirin treatment.
Gonzalez VD; Falconer K; Björkström NK; Blom KG; Weiland O; Ljunggren HG; Alaeus A; Sandberg JK
J Immunol; 2009 Nov; 183(10):6612-8. PubMed ID: 19846870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
